Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
Expiry Dates of Biostudies	Helmut	2004-10-05 19:04	0		12,796
Updated Canadian Guidelines	Helmut	2005-08-16 13:03	0		15,327
Investigational Products for BA/BE Investigational Products for BA/BE Investigational Products for BA/BE Investigational Products for BA/BE	debabrata	2005-10-19 06:58	3	2005-10-20 13:43	24,146
Argentina: bioanalytical guideline	Helmut	2005-11-19 18:20	0		9,161
ANVISA Approval ANVISA Approval ANVISA Approval ANVISA Approval	shiv	2006-01-25 06:39	3	2006-01-27 13:00	17,603
IRB approval IRB approval	SIVAPRASAD	2006-02-06 04:57	1	2006-02-06 05:22	11,394
Inclusion and Exclusion Inclusion and Exclusion (ANVISA)	devender_naik	2006-05-06 09:56	1	2006-05-06 08:21	10,601
IEC IEC IEC	Arulsingh Jayaraman	2006-04-06 12:54	2	2006-05-08 17:41	10,812
Parent Drug and Active Metabolite Parent Drug and Active Metabolite (FDA) Parent Drug and Active Metabolite (FDA) Parent Drug and Active Metabolite (FDA)	joyjac	2006-05-09 07:45	3	2006-05-10 06:22	12,005
ANDA approval ANDA approval in Germany ANDA approval	esreddy	2006-04-28 08:14	2	2006-05-10 09:36	11,597
GCP Guidelines GCP Guidelines	patel_prakash79	2006-05-19 07:56	1	2006-05-19 11:25	15,531
Canada: Records Related to Clinical Trials	Helmut	2006-05-31 12:01	0		5,392
restriction posture restriction	devender_naik	2006-04-27 10:12	2	2006-07-11 05:43	8,304
differences between EMEA and FDA guidelines EMEA and FDA guidelines	chintan98	2006-07-12 09:18	1	2006-07-12 10:32	7,737
Outlier consideration and re-dosing of Subjects Outlier consideration and re-dosing of Subjects Outlier consideration and re-dosing of Subjects	tripathy	2006-07-21 06:06	2	2006-07-24 03:52	8,263